GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Immunogen, Inc. (IMGN) [hlAlert]

Rating:
Buy IMGN
up 78.50 %

Immunogen, Inc. (IMGN) rated Buy with price target $14 by Brean Murray

Posted on: Friday,  Apr 29, 2011  11:25 AM ET by Brean Murray

Brean Murray rated Buy Immunogen, Inc. (NASDAQ: IMGN) on 04/29/2011. Previously Brean Murray rated Buy Immunogen, Inc. (NASDAQ: IMGN) on 10/08/2009.,
when the stock price was $8.00. Since then, Immunogen, Inc. has gained 78.50% as of 01/08/2016's recent price of $14.28.
If you would have followed the previous Brean Murray's recommendation on IMGN, you would have gained 78.5% of your investment in 2283 days.

ImmunoGen, Inc. develops pharmaceuticals, primarily for the treatment of cancer. The company's product candidates are called tumor-activated prodrugs and are based on its proprietary immunoconjugate technology platform. Unlike conventional chemotherapeutic agents, tumor-activated prodrugs are intended to deliver potent chemotherapy specifically to a tumor. Each tumor-activated drug immunoconjugate comprises a small-molecule drug which has been chemically linked to a monoclonal antibody.

Our equity research department is focused on fundamental analysis across the universe of over 200 small/mid cap stocks in our five target sectors. We are committed to providing proprietary action-oriented research to our institutional clients. Small cap growth focus. Our primary area of concentration is growth stocks with market capitalization of $200 million to $5 billion. Global perspective. We are covering U.S. listed stocks for companies domiciled in the U.S., China, Europe and Latin America, with our biggest concentration in the US and China. We were one of the first banks to aggressively expand our research to China and we believe we created one of the premier research franchises in small cap, U.S. listed Chinese companies to complement our strong domestic coverage. Disciplined stock selection. Our research analysts are focused on performing extensive bottoms up due diligence on companies under our coverage by leveraging their industry and management contacts. By combining our bottoms up work with our sector views we seek to generate a consistent flow of high conviction ideas for our clients. Diversified coverage. Our areas of expertise include technology, consumer, healthcare, resources and China small cap. We provide our clients with company-specific as well as sector-specific research across our target sectors.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
4/29/2011 11:25 AM Buy
None
13.16 14.00
as of 12/30/2011
1 Week down  -4.61 %
1 Month down  -4.69 %
3 Months up  5.65 %
1 YTD up  25.05 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
3/1/2011 8:25 AM Buy
None
9.04 11.00
8/27/2010 12:25 PM Buy
None
5.47 9.00
10/8/2009 8:25 AM Buy
None
8.00 14.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy